All In Biotech

Free tool

FAERS Monitor: Medical Air, Usp

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205765 or its brand name (Medical Air, Usp, Medical Air). Reports on generic versions are filed under their own applications.

Reports

22

Serious

20

91% of reports

Hospitalization

6

Death reported

2

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • cardiac arrest3
  • drug interaction3
  • atrial fibrillation2
  • blood pressure decreased2
  • cyanosis2
  • dystonia2
  • oxygen saturation decreased2
  • polyuria2
  • product quality issue2
  • sinus tachycardia2
  • underdose2
  • acidosis1
  • alanine aminotransferase increased1
  • anaesthetic complication cardiac1
  • anaphylactic reaction1

Reports by year received

View as table
YearReports
20042
20051
20062
20071
20081
20091
20111
20121
20143
20161
20171
20213
20233
20261

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,137 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaesthetic complication cardiac114073.62043.53,466
polyuria2233.662.3260
sinus tachycardia2134.735.9149
acidosis1125.118.430
cyanosis2121.632.4134
dystonia298.626.3108
cardiac arrestSignal334.712.168
oxygen saturation decreased234.09.135
blood pressure decreased228.87.730
underdose226.27.027
atrial fibrillation219.65.219
drug interactionSignal318.16.333
anaphylactic reaction117.32.53
alanine aminotransferase increased115.62.33
product quality issue214.13.813

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.